Autres langues Merck & Co., Inc. London S.E.

Actions

0QAH

US58933Y1055

Temps réel estimé Tradegate Autres places de cotation 11:48:32 01/07/2024			Varia. 5j.	Varia. 1 janv.
115,8 ^EUR	0,00%		+2,60%	0,00%

28/06	Merck : avis favorable pour Winrevair en Europe	CF
28/06	Merck annonce que le comité de l'Agence européenne des médicaments recommande l'approbation de Winrevair, un médicament contre les maladies cardiaques	MT

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE for Pneumococcal Vaccination in Appropriate Adults	28/06
EISAI - NEW EFFICACY DATA FOR NON-CLEAR CELL RENAL CELL CARCINOMA FROM KEYNOTE-B61 ADDED TO LENVIMA US LABEL SUPPORTING KEYTRUDA + LENVIMA INDICATION FOR THE FIRST-LINE TREATMENT OF ADULT PATIENTS WITH ADVANCED RCC	28/06
Immutep Reports Positive Topline Results from TACTI-003 Phase IIb Trial in First Line Head and Neck Cancer	28/06
Merck : avis favorable pour Winrevair en Europe	28/06
Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension	28/06
Merck Says European Medicines Agency's Committee Recommends Approval of Heart Disease Drug Winrevair	28/06
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)	28/06
Merck Receives Positive EU CHMP Opinion for WINREVAIR (Sotatercept) in Pulmonary Arterial Hypertension	28/06
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	28/06
Merck : l'ACIP recommande le Capvaxive chez les +65ans	28/06
Merck Says CDC's Advisory Committee Unanimously Recommends Pneumococcal Vaccine for Some Adults	28/06
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults	28/06
CDC?S ACIP Unanimously Recommends Merck?s CAPVAXIVE? (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults	28/06
Merck : CDC’s ACIP Unanimously Votes to Add Merck and Sanofi’s Pediatric Hexavalent Combination Vaccine to its Preferential Recommendation to Help Prevent Invasive Hib Disease in American Indian and Alaska Native Infants - Merck.com	27/06
ETF de la semana: Invertir en Europa fuera de Francia para evitar el riesgo político	27/06
Merck - Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer	27/06
FDA Turns Away Daiichi Sankyo, Merck Lung-Cancer ADC	27/06
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug	27/06
Merck : réponse de la FDA au sujet du patritumab deruxtecan	27/06
Aqilion Announces the Termination of the Licensing and Collaboration Agreement with Merck for the Joint Development of the TAK1 Programme Taking Aim at Chronic Inflammation	27/06

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Merck & Co., Inc. : Une vache à lait qui cache des vedettes

Le 11 juillet 2022 à 11:12